Qiao Chang-Jiang, Ali Hamed I, Ahn Kwang H, Kolluru Srikanth, Kendall Debra A, Lu Dai
Irma Lerma Rangel College of Pharmacy, Health Science Center, Texas A&M University, 1010 West Avenue B, Kingsville, TX 78363, United States; School of Pharmaceutical Engineering, Shenyang Pharmaceutical University, 103 Wenhua Road, Shenyang 110016, China.
Irma Lerma Rangel College of Pharmacy, Health Science Center, Texas A&M University, 1010 West Avenue B, Kingsville, TX 78363, United States.
Eur J Med Chem. 2016 Oct 4;121:517-529. doi: 10.1016/j.ejmech.2016.05.044. Epub 2016 May 24.
5-Chloro-3-ethyl-N-(4-(piperidin-1-yl)phenethyl)-1H-indole-2-carboxamide (ORG27569, 1) is a prototypical allosteric modulator for the cannabinoid CB1 receptor. Based on this indole-2-carboxamide scaffold, we designed and synthesized novel CB1 allosteric modulators that possess photoactivatable functionalities, which include benzophenone, phenyl azide, aliphatic azide and phenyltrifluoromethyldiazrine. To assess their allosteric effects, the dissociation constant (KB) and allosteric binding cooperativity factor (α) were determined and compared to their parent compounds. Within this series, benzophenone-containing compounds 26 and 27, phenylazide-containing compound 28, and the aliphatic azide containing compound 36b showed allosteric binding parameters (KB and α) comparable to their parent compound 1, 7, 8, and 9, respectively. We further assessed these modulators for their impact on G-protein coupling activity. Interestingly, these compounds exhibited negative allosteric modulator properties in a manner similar to their parent compounds, which antagonize agonist-induced G-protein coupling. These novel CB1 allosteric modulators, possessing photoactivatable functionalities, provide valuable tools for future photo-affinity labeling and mapping the CB1 allosteric binding site(s).
5-氯-3-乙基-N-(4-(哌啶-1-基)苯乙基)-1H-吲哚-2-甲酰胺(ORG27569,1)是大麻素CB1受体的典型变构调节剂。基于该吲哚-2-甲酰胺骨架,我们设计并合成了具有光活化功能的新型CB1变构调节剂,这些功能包括二苯甲酮、苯基叠氮化物、脂肪族叠氮化物和苯基三氟甲基重氮烯。为了评估它们的变构效应,测定了解离常数(KB)和变构结合协同因子(α),并与它们的母体化合物进行比较。在这个系列中,含二苯甲酮的化合物26和27、含苯基叠氮化物的化合物28以及含脂肪族叠氮化物的化合物36b的变构结合参数(KB和α)分别与其母体化合物1、7、8和9相当。我们进一步评估了这些调节剂对G蛋白偶联活性的影响。有趣的是,这些化合物以与其母体化合物类似的方式表现出负变构调节剂特性,它们拮抗激动剂诱导的G蛋白偶联。这些具有光活化功能的新型CB1变构调节剂为未来的光亲和标记和绘制CB1变构结合位点提供了有价值的工具。